Guinart-Cuadra, A.; Piedra, A.; Martínez-Recio, S.; Mulet, M.; Zamora, C.; Osuna-Gómez, R.; Cantó, E.; Ortiz, M.A.; Barba, A.; Sanz-Beltran, J.;
et al. Soluble Immune Checkpoints as Prognostic Biomarkers in Small Cell Lung Cancer Patients Treated with Chemotherapy and Anti-PD-L1. Int. J. Mol. Sci. 2026, 27, 6225.
https://doi.org/10.3390/ijms27146225
AMA Style
Guinart-Cuadra A, Piedra A, Martínez-Recio S, Mulet M, Zamora C, Osuna-Gómez R, Cantó E, Ortiz MA, Barba A, Sanz-Beltran J,
et al. Soluble Immune Checkpoints as Prognostic Biomarkers in Small Cell Lung Cancer Patients Treated with Chemotherapy and Anti-PD-L1. International Journal of Molecular Sciences. 2026; 27(14):6225.
https://doi.org/10.3390/ijms27146225
Chicago/Turabian Style
Guinart-Cuadra, Albert, Aida Piedra, Sergio Martínez-Recio, Maria Mulet, Carlos Zamora, Rubén Osuna-Gómez, Elisabet Cantó, Maria Angels Ortiz, Andrés Barba, Judit Sanz-Beltran,
and et al. 2026. "Soluble Immune Checkpoints as Prognostic Biomarkers in Small Cell Lung Cancer Patients Treated with Chemotherapy and Anti-PD-L1" International Journal of Molecular Sciences 27, no. 14: 6225.
https://doi.org/10.3390/ijms27146225
APA Style
Guinart-Cuadra, A., Piedra, A., Martínez-Recio, S., Mulet, M., Zamora, C., Osuna-Gómez, R., Cantó, E., Ortiz, M. A., Barba, A., Sanz-Beltran, J., Serra-López, J., Paz-Ares, L., Arriola, E., Moreno, A. L., Garcia-Campelo, R., Martí-Blanco, C., Isla, D., Callejo, Á., Majem, M.,
& Vidal, S.
(2026). Soluble Immune Checkpoints as Prognostic Biomarkers in Small Cell Lung Cancer Patients Treated with Chemotherapy and Anti-PD-L1. International Journal of Molecular Sciences, 27(14), 6225.
https://doi.org/10.3390/ijms27146225